Work

Circumventing Imatinib resistance in CML: Novel Telmisartan-based cell death modulators with improved activity and stability

Year: 2024

Type: article

Abstract: ) of 1.5-2.9 μM (ester derivatives) and 1.3-11.2 μM (amide derivatives).

Source: European Journal of Medicinal Chemistry

DOI: 10.1016/j.ejmech.2024.117106

Authors: Maximilian Gebhart, Mostafa Alilou, Ronald Gust, Stefan Salcher

Institutions: Universität Innsbruck, Innsbruck Medical University, Tyrolean Cancer Research Institute

Language: English

Topic: Chronic Myeloid Leukemia Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: hybrid

Estimated APC paid: $4,850

OpenAlex ID: W4404733292

FWCI: 0.534

Cites: 45

Cited by: 2

Related to: 10